Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Mentari Therapeutics
Mentari Therapeutics to Present at Upcoming Investor Conferences
November 9, 2026
Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing
November 9, 2026
Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
July 22, 2026
Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
July 20, 2026